KBC Group NV »

Ascendis Pharma A/s shares owned by KBC Group NV

Quarter-by-quarter ownership of Ascendis Pharma A/s shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Ascendis Pharma A/s

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A/s held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A/s by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-03-31 $229k 200k 1.15
2023-09-30 $184k 200k 0.92
2023-06-30 $184k 200k 0.92

More positions owned by KBC Group NV

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Pepsi (PEP)
Qualcomm (QCOM)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
Accenture Plc Ireland Shs Class A (ACN)
UnitedHealth (UNH)
Merck & Co (MRK)
Adobe Systems Incorporated (ADBE)

View all positions for KBC Group NV

Top funds holding Ascendis Pharma A/s

Wolverine Asset Management
Franklin Resources
Readystate Asset Management
Aviva
Citadel Advisors
Point72 Asset Management
Davidson Kempner Capital Management
Zazove Associates
State Street Corporation
Polar Capital Holdings
Aequim Alternative Investments
Calamos Advisors
SSI Investment Management
Partner Fund Management
Capstone Investment Advisors

View all funds holding Ascendis Pharma A/s